A Systematic Review and Methodological Evaluation of Published Cost-Effectiveness Analyses of Aromatase Inhibitors versus Tamoxifen in Early Stage Breast Cancer
出版年份 2013 全文链接
标题
A Systematic Review and Methodological Evaluation of Published Cost-Effectiveness Analyses of Aromatase Inhibitors versus Tamoxifen in Early Stage Breast Cancer
作者
关键词
Breast cancer, Adverse events, Aromatase inhibitors, Cost-effectiveness analysis, Systematic reviews, Womens health, Death rates, Cancer treatment
出版物
PLoS One
Volume 8, Issue 5, Pages e62614
出版商
Public Library of Science (PLoS)
发表日期
2013-05-07
DOI
10.1371/journal.pone.0062614
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Meta-analysis: Excess Mortality After Hip Fracture Among Older Women and Men
- (2013) Patrick Haentjens ANNALS OF INTERNAL MEDICINE
- Conceptualizing a Model
- (2012) Mark Roberts et al. MEDICAL DECISION MAKING
- Model Parameter Estimation and Uncertainty Analysis
- (2012) Andrew H. Briggs et al. MEDICAL DECISION MAKING
- A glimpse into the black box of cost-effectiveness analyses
- (2011) A. A. John-Baptiste et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Industry involvement and baseline assumptions of cost-effectiveness analyses: diagnostic accuracy of the Papanicolaou test
- (2011) N. P. Polyzos et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Toxicity of Adjuvant Endocrine Therapy in Postmenopausal Breast Cancer Patients: A Systematic Review and Meta-analysis
- (2011) Eitan Amir et al. JNCI-Journal of the National Cancer Institute
- Delivering affordable cancer care in high-income countries
- (2011) Richard Sullivan et al. LANCET ONCOLOGY
- Bending the Cost Curve in Cancer Care
- (2011) Thomas J. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Conflict of interest in economic analyses of aromatase inhibitors in breast cancer: a systematic review
- (2010) Sekwon Jang et al. BREAST CANCER RESEARCH AND TREATMENT
- Modeling in pharmacoeconomic studies: Funding sources and outcomes
- (2010) Livio Garattini et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Cost-Effectiveness Analysis of Adjuvant Hormonal Treatments for Women with Postmenopausal Hormone-Receptor Positive Early Breast Cancer in the Korean Context
- (2010) Hye-Jae Lee et al. Journal of Breast Cancer
- When is Cancer Care Cost-Effective? A Systematic Overview of Cost–Utility Analyses in Oncology
- (2010) Dan Greenberg et al. JNCI-Journal of the National Cancer Institute
- Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial
- (2010) Jack Cuzick et al. LANCET ONCOLOGY
- Cost-Effectiveness Analysis of Anastrozole versus Tamoxifen in Adjuvant Therapy for Early-Stage Breast Cancer – A Health-Economic Analysis Based on the 100-Month Analysis of the ATAC Trial and the German Health System
- (2010) Michael P. Lux et al. ONKOLOGIE
- Fracture risk and adjuvant hormonal therapy among a population-based cohort of older female breast cancer patients
- (2010) J. M. Neuner et al. OSTEOPOROSIS INTERNATIONAL
- Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial
- (2009) M. Rabaglio et al. ANNALS OF ONCOLOGY
- Long-term effectiveness and cost-effectiveness of screening for Hepatitis C virus infection
- (2009) G. Sroczynski et al. EUROPEAN JOURNAL OF PUBLIC HEALTH
- International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?
- (2009) Takeru Shiroiwa et al. HEALTH ECONOMICS
- Up-Front Use of Aromatase Inhibitors As Adjuvant Therapy for Breast Cancer: The Emperor Has No Clothes
- (2009) Bostjan Seruga et al. JOURNAL OF CLINICAL ONCOLOGY
- Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen
- (2009) Mitch Dowsett et al. JOURNAL OF CLINICAL ONCOLOGY
- Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Cost-effectiveness of anastrozole, in comparison with tamoxifen, in the adjuvant treatment of early breast cancer in Brazil
- (2009) Marcelo Fonseca et al. Revista da Associacao Medica Brasileira
- Intergroup Exemestane Study mature analysis: overall survival data
- (2008) Jacek Jassem ANTI-CANCER DRUGS
- Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial
- (2008) LANCET ONCOLOGY
- Methodological Issues in Evaluating Cost Effectiveness of Adjuvant Aromatase Inhibitors in Early Breast Cancer
- (2008) Lieven Annemans PHARMACOECONOMICS
- Subgroups and Heterogeneity in Cost-Effectiveness Analysis
- (2008) Mark Sculpher PHARMACOECONOMICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started